JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB256889

Human DDIT3 knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(1 Publication)

DDIT3 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon2.

View Alternative Names

C/EBP Homology Protein, C/EBP zeta, C/EBP-homologous protein, C/EBP-homologous protein 10, CCAAT/enhancer binding protein homologous protein, CHOP, CHOP-10, DDIT3_HUMAN, DNA Damage Inducible Transcript 3, DNA damage-inducible transcript 3 protein, GADD 153, Growth Arrest and DNA Damage Inducible Protein 153, Growth arrest and DNA damage-inducible protein GADD153, MGC4154

4 Images
Western blot - Human DDIT3 knockout HeLa cell lysate (AB256889)
  • WB

Supplier Data

Western blot - Human DDIT3 knockout HeLa cell lysate (AB256889)

All lanes : Anti-DDIT3 antibody [9C8] (ab11419)

Lane 1 : Wild-type HeLa Vehicle Control Tunicamycin (20ug/mL, 4h) cell lysate
Lane 2 : Wild-type HeLa Treated Tunicamycin (20ug/mL, 4h) cell lysate
Lane 3 : DDIT3 knockout HeLa Vehicle Control Tunicamycin (20ug/mL, 4h) cell lysate
Lane 4 : DDIT3 knockout HeLa Treated Tunicamycin (20ug/mL, 4h) cell lysate

Performed under reducing conditions.

Observed band size : 25 kDa

False colour image of Western blot : Anti-DDIT3 antibody [9C8] staining at 5 μg/ml, shown in green; Rabbit anti-alpha Tubulin antibody [EP1332Y] (ab52866) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab11419 was shown to bind specifically to DDIT3. A band was observed at 25 kDa in wild-type y cell lysates with no signal observed at this size in DDIT3 knockout cell line ab265760 (knockout cell lysate ab256889). To generate this image, wild-type and DDIT3 knockout y cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged.Secondary antibodies used were Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed (ab216772) and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed (ab216777) at 1/20000 dilution.

false

Western blot - Human DDIT3 knockout HeLa cell lysate (AB256889)
  • WB

Lab

Western blot - Human DDIT3 knockout HeLa cell lysate (AB256889)

False colour image of Western blot : Anti-DDIT3 antibody [9C8] staining at 5 µg/ml, shown in green; Rabbit anti-alpha Tubulin antibody [EP1332Y] (ab52866) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab11419 was shown to bind specifically to DDIT3. A band was observed at 25 kDa in wild-type y cell lysates with no signal observed at this size in DDIT3 knockout cell line ab265760 (knockout cell lysate ab256889). To generate this image, wild-type and DDIT3 knockout y cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged.Secondary antibodies used were Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed (ab216772) and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed (ab216777) at 1/20000 dilution.

All lanes:

Western blot - Anti-CHOP antibody [9C8] (<a href='/en-us/products/primary-antibodies/chop-antibody-9c8-ab11419'>ab11419</a>) at 5 µg/mL

Lane 1:

Wild-type HeLa Vehicle Control Tunicamycin cell lysate at 20 µg

Lane 2:

Wild-type HeLa Treated Tunicamycin cell lysate at 20 µg

Lane 3:

DDIT3 knockout HeLa Vehicle Control Tunicamycin cell lysate at 20 µg

Lanes 3 - 4:

Western blot - Human DDIT3 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-ddit3-knockout-hela-cell-line-ab265760'>ab265760</a>)

Lanes 3 - 4:

Western blot - Human DDIT3 knockout HeLa cell lysate (ab256889)

Lane 4:

DDIT3 knockout HeLa Treated Tunicamycin cell lysate at 20 µg

Predicted band size: 19 kDa

Observed band size: 25 kDa

false

Western blot - Human DDIT3 knockout HeLa cell lysate (AB256889)
  • WB

Supplier Data

Western blot - Human DDIT3 knockout HeLa cell lysate (AB256889)

Lanes 1 - 5 : Merged signal (red and green). Green - ab11419 observed at 26 kDa. Red - loading control ab52866 (Rabbit anti-alpha Tubulin antibody [EP1332Y]) observed at 55kDa.

ab11419 was shown to react with DDIT3 in wild-type SW480 cells in western blot with loss of signal observed in DDIT3 knockout cell line ab269585 (knockout cell lysate ab270708). Wild-type and DDIT3 knockout SW480 cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab11419 and ab52866 (Rabbit anti-alpha Tubulin antibody [EP1332Y]) overnight at 4°C at 5 µg/ml and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed (ab216772) and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed (ab216777) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-CHOP antibody [9C8] (<a href='/en-us/products/primary-antibodies/chop-antibody-9c8-ab11419'>ab11419</a>) at 5 µg/mL

Lane 1:

Wild-type HeLa Vehicle Control Tunicamycin (20ug/mL, 4h) cell lysate at 20 µg

Lane 2:

Wild-type HeLa Treated Tunicamycin (20ug/mL, 4h) cell lysate at 20 µg

Lane 3:

DDIT3 knockout HeLa Vehicle Control Tunicamycin (20ug/mL, 4h) cell lysate at 20 µg

Lanes 3 - 4:

Western blot - Human DDIT3 knockout SW480 cell line (<a href='/en-us/products/cell-lines/human-ddit3-knockout-sw480-cell-line-ab269585'>ab269585</a>)

Lanes 3 - 4:

Western blot - Human DDIT3 knockout HeLa cell lysate (ab256889)

Lane 4:

DDIT3 knockout HeLa Treated Tunicamycin (20ug/mL, 4h) cell lysate at 20 µg

Predicted band size: 19 kDa

Observed band size: 25 kDa

false

Sanger Sequencing - Human DDIT3 knockout HeLa cell lysate (AB256889)
  • Sanger seq

Unknown

Sanger Sequencing - Human DDIT3 knockout HeLa cell lysate (AB256889)

Homozygous : 1 bp insertion in exon2

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon2.

Disease

Adenocarcinoma

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Sanger seq": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab256889-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human DDIT3 knockout HeLa cell lysate", "number":"AB256889-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB256889-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
DDIT3
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

DDIT3 also known as CHOP (C/EBP homologous protein) is a transcription factor commonly expressed in cells under stress conditions such as endoplasmic reticulum stress. It has a molecular weight of approximately 29 kDa. As part of the system that manages cell stress responses DDIT3 expression can occur in various tissues but it is particularly notable in the context of cellular stress regulation. Researchers often use DDIT3 immunohistochemistry to study its presence and expression pattern in different tissues.
Biological function summary

DDIT3 plays a significant role in mediating cellular stress responses and promoting apoptosis when adaptive pathways fail. DDIT3 is not typically part of a multi-subunit complex but it acts in concert with other stress-related proteins to modulate gene expression. By inducing apoptosis DDIT3 helps remove severely damaged cells maintaining overall tissue health. However excessive DDIT3 activity under prolonged stress can lead to cell loss and tissue damage.

Pathways

DDIT3 is involved in the unfolded protein response (UPR) and endoplasmic reticulum stress pathways. It interacts with proteins such as ATF4 and PERK which are part of the mechanism that governs these pathways. DDIT3 induction contributes to the UPR pathway balancing the cell's fate between repair and apoptosis. This balance is important for cell survival under stress and avoids detrimental cellular damage.

DDIT3 has a strong connection with diabetes and neurodegenerative diseases. In diabetes DDIT3 overactivation can result in pancreatic beta-cell apoptosis worsening the disease's progression. Furthermore its involvement in neurodegenerative diseases includes its association with the accumulation of misfolded proteins exacerbating cellular stress conditions. DDIT3's interaction with proteins such as BCL2 further influences disease pathways by enhancing apoptotic signals.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

BMC pharmacology & toxicology 26:115 PubMed40457385

2025

Bisacurone ameliorates myocardial ischemia/reperfusion injury in rats: regulation of inflammatory and apoptosis pathways via CHOP/GRP78 proteins.

Applications

Unspecified application

Species

Unspecified reactive species

Xueyan Liao,Qi Wang,Xiaoming Yang,Yuan Yao,Dezhi Zhu,Jing Feng,Kechun Wang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com